Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

While drug developers work to mitigate the side effects associated with GLP-1–based obesity drugs, recent studies reveal that ...

In older adults with diabetes, GLP-1 receptor agonists were tied to a slightly lower risk for depression compared with one diabetes drug class but not another, a target emulation trial using Medicare ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...

Muscle Preservation: On average, GLP-1 users lose 10% of muscle mass within 1–4 years. Ideal Protein’s high-protein protocol helped participants preserve 95-98% of lean mass during weight loss, ...